Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10308764 | Seizure | 2005 | 5 Pages |
Abstract
LEV is an effective adjunctive treatment for refractory idiopathic and localisation-related epilepsies. Many patients who responded optimally to LEV did so at 1000Â mg per day or less.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Rajiv Mohanraj, Pamela G. Parker, Linda J. Stephen, Martin J. Brodie,